Literature DB >> 29978341

Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases.

D Thirumal Kumar1, Hend Ghasan Eldous2, Zainab Alaa Mahgoub2, C George Priya Doss3, Hatem Zayed4.   

Abstract

Gaucher's disease (GD) is a genetic disorder in which glucocerebroside accumulates in cells and specific organs. It is broadly classified into type I, type II and type III. Patients with GD are at high risk of Parkinson's disease (PD), and the clinical and pathological presentation of GD patients with PD is almost identical to idiopathic PD. Several experimental models like cell culture, animal models, and transgenic mice models were used to understand the molecular mechanism behind GD and PD association; however, such mechanism remains unclear. In this context, based on literature reports, we identified the most common mutations K198T, E326K, T369M, N370S, V394L, D409H, L444P, and R496H, in the Glucosylceramidase (GBA) protein that are known to cause GD1, and represent a risk of developing PD. However, to date, no computational analyses have designed to elucidate the potential functional role of GD mutations with increased risk of PD. The present computational pipeline allows us to understand the structural and functional significance of these GBA mutations with PD. Based on the published data, the most common and severe mutations were E326K, N370S, and L444P, which further selected for our computational analysis. PredictSNP and iStable servers predicted L444P mutant to be the most deleterious and responsible for the protein destabilization, followed by the N370S mutation. Further, we used the structural analysis and molecular dynamics approach to compare the most frequent deleterious mutations (N370S and L444P) with the mild mutation E326K. The structural analysis demonstrated that the location of E326K and N370S in the alpha helix region of the protein whereas the mutant L444P was in the starting region of the beta sheet, which might explain the predicted pathogenicity level and destabilization effect of the L444P mutant. Finally, Molecular Dynamics (MD) at 50 ns showed the highest deviation and fluctuation pattern in the L444P mutant compared to the two mutants E326K and N370S and the native protein. This was consistent with more loss of intramolecular hydrogen bonds and less compaction of the radius of gyration in the L444P mutant. The proposed study is anticipated to serve as a potential platform to understand the mechanism of the association between GD and PD, and might facilitate the process of drug discovery against both GD and PD.

Entities:  

Keywords:  E326K; GBA; Gaucher’s disease; L444P; N370S; Parkinson disease; Variant classification

Mesh:

Year:  2018        PMID: 29978341     DOI: 10.1007/s11011-018-0286-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  85 in total

1.  Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S.

Authors:  Marc N Offman; Marcin Krol; Israel Silman; Joel L Sussman; Anthony H Futerman
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

2.  Epidemiology and natural history of Gaucher's disease.

Authors:  Atul Mehta
Journal:  Eur J Intern Med       Date:  2006-11       Impact factor: 4.487

Review 3.  Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.

Authors:  S Pablo Sardi; Seng H Cheng; Lamya S Shihabuddin
Journal:  Prog Neurobiol       Date:  2015-01-06       Impact factor: 11.685

Review 4.  Gaucher disease and other storage disorders.

Authors:  Gregory A Grabowski
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

Review 5.  Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

Authors:  Kathleen S Hruska; Mary E LaMarca; C Ronald Scott; Ellen Sidransky
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

6.  THE METABOLISM OF GLUCOCEREBROSIDES. I. PURIFICATION AND PROPERTIES OF A GLUCOCEREBROSIDE-CLEAVING ENZYME FROM SPLEEN TISSUE.

Authors:  R O BRADY; J KANFER; D SHAPIRO
Journal:  J Biol Chem       Date:  1965-01       Impact factor: 5.157

7.  Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Authors:  N Tayebi; J Walker; B Stubblefield; E Orvisky; M E LaMarca; K Wong; H Rosenbaum; R Schiffmann; B Bembi; E Sidransky
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

8.  Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models.

Authors:  Alvaro Sanchez-Martinez; Michelle Beavan; Matthew E Gegg; Kai-Yin Chau; Alexander J Whitworth; Anthony H V Schapira
Journal:  Sci Rep       Date:  2016-08-19       Impact factor: 4.379

9.  α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.

Authors:  Seung Pil Yun; Donghoon Kim; Sangjune Kim; SangMin Kim; Senthilkumar S Karuppagounder; Seung-Hwan Kwon; Saebom Lee; Tae-In Kam; Suhyun Lee; Sangwoo Ham; Jae Hong Park; Valina L Dawson; Ted M Dawson; Yunjong Lee; Han Seok Ko
Journal:  Mol Neurodegener       Date:  2018-01-08       Impact factor: 14.195

10.  The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.

Authors:  Raquel Duran; Niccolo E Mencacci; Aikaterini V Angeli; Maryam Shoai; Emma Deas; Henry Houlden; Atul Mehta; Derralynn Hughes; Timothy M Cox; Patrick Deegan; Anthony H Schapira; Andrew J Lees; Patricia Limousin; Paul R Jarman; Kailash P Bhatia; Nicholas W Wood; John Hardy; Tom Foltynie
Journal:  Mov Disord       Date:  2012-12-05       Impact factor: 10.338

View more
  8 in total

1.  A computational approach to analyse the amino acid variants of GLB1 protein causing GM1 Gangliosidosis.

Authors:  K Priyanka; N Madhana Priya; R Magesh
Journal:  Metab Brain Dis       Date:  2021-01-04       Impact factor: 3.584

2.  Hexaconazole exposure ravages biosynthesis pathway of steroid hormones: revealed by molecular dynamics and interaction.

Authors:  Sayed Aliul Hasan Abdi; Abdulaziz Alzahrani; Saleh Alghamdi; Ali Alquraini; Adel Alghamdi
Journal:  Toxicol Res (Camb)       Date:  2021-12-16       Impact factor: 3.524

3.  Exome Analysis Identifies a Novel Compound Heterozygous Alteration in TGM1 Gene Leading to Lamellar Ichthyosis in a Child From Saudi Arabia: Case Presentation.

Authors:  Sami Raja Alallasi; Amal A Kokandi; Babajan Banagnapali; Noor Ahmad Shaik; Bandar Ali Al-Shehri; Nuha Mohammad Alrayes; Jumana Yousuf Al-Aama; Musharraf Jelani
Journal:  Front Pediatr       Date:  2019-02-21       Impact factor: 3.418

4.  Deciphering the Role of Filamin B Calponin-Homology Domain in Causing the Larsen Syndrome, Boomerang Dysplasia, and Atelosteogenesis Type I Spectrum Disorders via a Computational Approach.

Authors:  Udhaya Kumar S; Srivarshini Sankar; Salma Younes; Thirumal Kumar D; Muneera Naseer Ahmad; Sarah Samer Okashah; Balu Kamaraj; Abeer Mohammed Al-Subaie; George Priya Doss C; Hatem Zayed
Journal:  Molecules       Date:  2020-11-26       Impact factor: 4.411

Review 5.  Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major Features.

Authors:  Nattakarn Limphaibool; Piotr Iwanowski; Marte Johanne Veilemand Holstad; Katarzyna Perkowska
Journal:  Front Neurol       Date:  2018-10-12       Impact factor: 4.003

6.  In Silico Analysis of Missense Mutations as a First Step in Functional Studies: Examples from Two Sphingolipidoses.

Authors:  Ana Joana Duarte; Diogo Ribeiro; Luciana Moreira; Olga Amaral
Journal:  Int J Mol Sci       Date:  2018-10-31       Impact factor: 5.923

7.  Computational Analysis of nsSNPs of ADA Gene in Severe Combined Immunodeficiency Using Molecular Modeling and Dynamics Simulation.

Authors:  Soukaina Essadssi; Al Mehdi Krami; Lamiae Elkhattabi; Zouhair Elkarhat; Ghita Amalou; Houria Abdelghaffar; Hassan Rouba; Abdelhamid Barakat
Journal:  J Immunol Res       Date:  2019-11-03       Impact factor: 4.818

8.  Bioinformatics classification of mutations in patients with Mucopolysaccharidosis IIIA.

Authors:  Himani Tanwar; D Thirumal Kumar; C George Priya Doss; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2019-08-05       Impact factor: 3.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.